🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Phase II

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma NCT06342167Phase 210 sites📍 Beijing📍 Fujian📍 Handan Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease NCT07513844NA1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: Low-Intensity Focused Ultrasound Stimulation（LIFU） Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） NCT06767007Phase 21 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer NCT06525428Phase 21 site📍 Shanghai Fudan University · Tests: standard systemic therapy combined with high/low-dose radiotherapy plus toripalimab A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites📍 Phoenix📍 Los Angeles📍 Orlando Iovance Biotherapeutics, Inc. · Tests: Lifileucel Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer NCT06451211Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Tislelizumab, Oxaliplatin, S-1, Capecitabine Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma NCT04448522Phase 36 sites📍 Guangzhou📍 Guangzhou📍 Shaoguan Sun Yat-sen University · Tests: reduced dosage IMRT, conventional dosage IMRT Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor NCT05933395Phase 21 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: Fulvestrant, Neratinib, Alpelisib, Everolimus, Abemaciclib A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site📍 Irving Turn Therapeutics · Tests: GX-03, Vehicle Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC NCT06739928Phase 21 site📍 Guangzhou Guangzhou Institute of Respiratory Disease · Tests: Irinotecan liposome (II) combined with adebrelimab and carboplatin, etoposide combined with adebrelimab and carboplatin Breast Cancer Survivorship Biorepository NCT05786664n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Survey Administration Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation NCT06843551Phase 21 site📍 Miami Benjamin Spieler · Tests: Stereotactic Body Radiation Therapy, Botensilimab, Balstilimab Combination Study of Antibiotics With Enzalutamide (PROMIZE) NCT06126731Phase 1, Phase 22 sites📍 Bellinzona📍 Sutton Institute of Cancer Research, United Kingdom · Tests: Enzalutamide 40mg, Amoxicillin 500mg, Metronidazole 400mg, Vancomycin 125mg, Ciprofloxacin 500g Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix NCT04723095n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Follow-Up, Medical Chart Review Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer NCT07643012NA1 site📍 New Brunswick Rutgers, The State University of New Jersey · Tests: MR-guided adaptive pelvic intensity-modulated radiation therapy (IMRT) Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations NCT06947811Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Almonertinib, Palbociclib To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies NCT07795034Phase 21 site📍 Xiamen Neuboron Bio-SciTech Co., Ltd. · Tests: Boron Neutron Capture Therapy A Study of SHR-2173 in Participants With Primary IgA Nephropathy NCT07354932Phase 22 sites📍 Guangzhou📍 Shanghai Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-2173 injection, SHR-2173 injection, SHR-2173 injection, Placebo A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder NCT07475806Phase 266 sites📍 Little Rock📍 Stanford📍 Chicago Astellas Pharma Global Development, Inc. · Tests: Enfortumab Vedotin, Pembrolizumab Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site📍 Atlanta Emory University · Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER NCT07178808Phase 21 site📍 Gilbert Banner Health · Tests: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC NCT06424899Phase 21 site📍 Hangzhou Zeng Jian · Tests: Adebrelimab, radical chemoradiotherapy, Platinum based chemotherapy Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC) NCT07055399Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: neoadjuvant chemo-immunotherapy: Iparomlimab and tuvonralimab plus cisplatin,nab-paclitaxel for 1 cycle and Iparomlimab… FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites📍 Guangzhou📍 Chengdu Guangdong Association of Clinical Trials · Tests: Sintilimab Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites📍 Atlanta📍 Chicago📍 Boston Dana-Farber Cancer Institute · Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma NCT07096778Phase 231 sites📍 Phoenix📍 San Francisco📍 Jacksonville CellCentric Ltd. · Tests: Inobrodib, Pomalidomide, Dexamethasone
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy